NO20062130L - 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft - Google Patents
4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreftInfo
- Publication number
- NO20062130L NO20062130L NO20062130A NO20062130A NO20062130L NO 20062130 L NO20062130 L NO 20062130L NO 20062130 A NO20062130 A NO 20062130A NO 20062130 A NO20062130 A NO 20062130A NO 20062130 L NO20062130 L NO 20062130L
- Authority
- NO
- Norway
- Prior art keywords
- ylamino
- pyrazol
- cancer
- treatment
- pyrimidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbindelse med formel (I) hvor substituentene er som definert i teksten for anvendelse til å modulere insulin-lignende vekstfaktor 1 -reseptor-aktivitet hos et varmblodig dyr, så som mennesket.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0324335A GB0324335D0 (en) | 2003-10-17 | 2003-10-17 | Novel compounds |
GB0412194A GB0412194D0 (en) | 2004-06-02 | 2004-06-02 | Novel compounds |
PCT/GB2004/004307 WO2005040159A1 (en) | 2003-10-17 | 2004-10-11 | 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062130L true NO20062130L (no) | 2006-05-12 |
Family
ID=34525049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062130A NO20062130L (no) | 2003-10-17 | 2006-05-12 | 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft |
Country Status (16)
Country | Link |
---|---|
US (1) | US7579349B2 (no) |
EP (1) | EP1678169B1 (no) |
JP (1) | JP2007510626A (no) |
KR (1) | KR20060123164A (no) |
AR (1) | AR046338A1 (no) |
AU (1) | AU2004283137A1 (no) |
BR (1) | BRPI0415398A (no) |
CA (1) | CA2542522A1 (no) |
DE (1) | DE602004022187D1 (no) |
ES (1) | ES2328820T3 (no) |
IL (1) | IL174989A0 (no) |
NO (1) | NO20062130L (no) |
SA (1) | SA04250338B1 (no) |
TW (1) | TW200530229A (no) |
UY (1) | UY28565A1 (no) |
WO (1) | WO2005040159A1 (no) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0302173A2 (hu) | 2000-09-15 | 2003-09-29 | Vertex Pharmaceuticals Incorporated | Protein kináz inhibitorokként alkalmazható pirazolvegyületek |
US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
WO2004072029A2 (en) | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
AU2005214378A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
CA2587427A1 (en) | 2004-11-17 | 2006-05-26 | Miikana Therapeutics, Inc. | Kinase inhibitors |
ATE519759T1 (de) | 2004-12-30 | 2011-08-15 | Exelixis Inc | Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren |
JP2008534481A (ja) * | 2005-03-23 | 2008-08-28 | アストラゼネカ アクチボラグ | インスリン様増殖因子−1受容体活性の阻害剤としての2−アゼチジニル−4−(1h−ピラゾール−3−イルアミノ)ピリミジン |
JP2008534662A (ja) * | 2005-04-05 | 2008-08-28 | アストラゼネカ アクチボラグ | 抗癌剤として使用されるピリミジン誘導体 |
GB0506886D0 (en) * | 2005-04-05 | 2005-05-11 | Astrazeneca Ab | Chemical compounds |
WO2007023382A2 (en) * | 2005-08-25 | 2007-03-01 | Pfizer Inc. | Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
JP2009508833A (ja) * | 2005-09-16 | 2009-03-05 | アストラゼネカ アクチボラグ | Igf−1rチロシンキナーゼ活性の阻害のためのピリミジン誘導体類 |
KR101487027B1 (ko) * | 2005-09-30 | 2015-01-28 | 미카나 테라퓨틱스, 인크. | 치환된 피라졸 화합물 |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
AR056763A1 (es) | 2005-11-03 | 2007-10-24 | Vertex Pharma | Aminopirimidinas sustituidas con tiazol o pirazol,utiles como agentes anticancer y composiciones farmaceuticas que las contienen. |
WO2007059299A1 (en) * | 2005-11-16 | 2007-05-24 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
CA2650572C (en) * | 2006-04-27 | 2013-09-10 | Banyu Pharmaceutical Co., Ltd. | Novel aminopyridine derivatives having aurora a selective inhibitory action |
MX2008016523A (es) * | 2006-06-30 | 2009-01-19 | Astrazeneca Ab | Derivados de pirimidina utiles en el tratamiento de cancer. |
CA2656290A1 (en) | 2006-07-05 | 2008-01-10 | Exelixis, Inc. | Methods of using igf1r and abl kinase modulators |
US20100120717A1 (en) | 2006-10-09 | 2010-05-13 | Brown Jason W | Kinase inhibitors |
EP2086965B1 (en) | 2006-11-02 | 2010-02-10 | Vertex Pharmaceuticals, Inc. | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
EP2099787B1 (en) | 2006-12-19 | 2010-07-21 | Vertex Pharmaceuticals, Inc. | Aminopyrimidines useful as inhibitors of protein kinases |
MX2009009590A (es) | 2007-03-09 | 2009-11-10 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de proteinas cinasas. |
AU2008226466B2 (en) * | 2007-03-09 | 2013-06-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
WO2008112646A1 (en) | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
WO2008117051A1 (en) * | 2007-03-27 | 2008-10-02 | Astrazeneca Ab | S-6-meth0xy-2- (2- (3- (pyrimid-2-yl) is0xaz0l-5-yl) pyrrolidin-1-yl) -4- (5-methyl-ih-pyrazol-s-ylamino) pyrimidine and polymorphic forms thereof as modulators of the insulin-like growth |
JP2010523700A (ja) | 2007-04-13 | 2010-07-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼインヒビターとして有用なアミノピリミジン |
CA2685876A1 (en) | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
CA2694381A1 (en) | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
WO2008154026A1 (en) * | 2007-06-11 | 2008-12-18 | Miikana Therapeutics, Inc. | Substituted pyrazole compounds |
WO2009018415A1 (en) * | 2007-07-31 | 2009-02-05 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
WO2009019518A1 (en) * | 2007-08-09 | 2009-02-12 | Astrazeneca Ab | Pyrimidine compounds having a fgfr inhibitory effect |
US8278313B2 (en) | 2008-03-11 | 2012-10-02 | Abbott Laboratories | Macrocyclic spiro pyrimidine derivatives |
US8436005B2 (en) | 2008-04-03 | 2013-05-07 | Abbott Laboratories | Macrocyclic pyrimidine derivatives |
CA2755806A1 (en) * | 2009-03-23 | 2010-09-30 | Msd K.K. | Novel aminopyridine derivatives having aurora a selective inhibitory action |
JP2012521426A (ja) * | 2009-03-24 | 2012-09-13 | Msd株式会社 | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
US20110053916A1 (en) | 2009-08-14 | 2011-03-03 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
ES2553620T3 (es) | 2009-12-21 | 2015-12-10 | Bayer Cropscience Ag | Bis(difluorometil)pirazoles como fungicidas |
US20120122928A1 (en) | 2010-08-11 | 2012-05-17 | Bayer Cropscience Ag | Heteroarylpiperidine and -Piperazine Derivatives as Fungicides |
EP2423210A1 (de) | 2010-08-25 | 2012-02-29 | Bayer CropScience AG | Heteroarylpiperidin- und -piperazinderivate als Fungizide |
US8759527B2 (en) | 2010-08-25 | 2014-06-24 | Bayer Cropscience Ag | Heteroarylpiperidine and -piperazine derivatives as fungicides |
US20140005224A1 (en) | 2010-10-27 | 2014-01-02 | Bayer Intellectual Property Gmbh | Heteroaryl piperidine and heteroaryl piperazine derivatives as fungicides |
MX352307B (es) | 2011-02-01 | 2017-11-17 | Bayer Ip Gmbh | Derivados de heteroarilpiperidina y -piperazina como fungicidas. |
EP2532233A1 (en) | 2011-06-07 | 2012-12-12 | Bayer CropScience AG | Active compound combinations |
US10004232B2 (en) | 2011-09-15 | 2018-06-26 | Bayer Intellectual Property Gmbh | Piperidine pyrazoles as fungicides |
ES2675506T3 (es) | 2011-12-27 | 2018-07-11 | Bayer Cropscience Aktiengesellschaft | Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas |
EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
TW201838974A (zh) | 2017-04-19 | 2018-11-01 | 印度商Pi工業公司 | 具殺菌性質之雜環化合物 |
EP3820500A4 (en) * | 2018-07-13 | 2022-04-13 | Teqla Therapeutics, Inc. | USE OF BCL6 INHIBITORS TO TREAT AUTOIMMUNE DISEASES |
AR120376A1 (es) | 2019-11-11 | 2022-02-09 | Pi Industries Ltd | Heteroaril piperidiniletanonas sustituidas con actividad fungicida |
UY38941A (es) | 2019-11-11 | 2021-06-30 | Pi Industries Ltd | Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas |
UY38940A (es) | 2019-11-11 | 2021-06-30 | Pi Industries Ltd | Nuevas piridiniloxi piperidiniletanonas sustituidas |
TW202237143A (zh) | 2020-12-10 | 2022-10-01 | 南韓商Lg化學股份有限公司 | 酸(Boronic Acid)化合物 |
WO2022211595A1 (ko) * | 2021-04-01 | 2022-10-06 | 주식회사 엘지화학 | 옥사디아졸 화합물 및 이를 포함하는 약제학적 조성물 |
CN117794527A (zh) * | 2021-06-04 | 2024-03-29 | 学校法人京都药科大学 | 新型活化amp的蛋白激酶活化剂 |
WO2023163712A1 (en) * | 2022-02-25 | 2023-08-31 | Nalo Therapeutics | Modulators of myc family proto-oncogene protein |
WO2023164611A1 (en) * | 2022-02-25 | 2023-08-31 | Nalo Therapeutics | Modulators of myc family proto-oncogene protein |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2426180A1 (de) | 1974-05-29 | 1975-12-18 | Bayer Ag | Verfahren zum faerben von polyurethankunststoffen |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
JP2002523497A (ja) | 1998-08-29 | 2002-07-30 | アストラゼネカ・アクチエボラーグ | ピリミジン化合物 |
US6337338B1 (en) | 1998-12-15 | 2002-01-08 | Telik, Inc. | Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
DE19917785A1 (de) | 1999-04-20 | 2000-10-26 | Bayer Ag | 2,4-Diamino-pyrimidin-Derivate |
AU775360B2 (en) | 1999-09-24 | 2004-07-29 | Janssen Pharmaceutica N.V. | Antiviral compositions |
HUP0301117A3 (en) | 2000-02-17 | 2004-01-28 | Amgen Inc Thousand Oaks | Imidazole derivatives kinase inhibitors, their use, process for their preparation and pharmaceutical compositions containing them |
GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
EP1282607B1 (en) | 2000-05-08 | 2015-11-11 | Janssen Pharmaceutica NV | Prodrugs of hiv replication inhibiting pyrimidines |
HUP0302173A2 (hu) | 2000-09-15 | 2003-09-29 | Vertex Pharmaceuticals Incorporated | Protein kináz inhibitorokként alkalmazható pirazolvegyületek |
ES2265452T3 (es) | 2000-12-21 | 2007-02-16 | Vertex Pharmaceuticals Incorporated | Compuestos de pirazol utiles como inhibidores de la proteina quinasa. |
SE0104140D0 (sv) | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
-
2004
- 2004-10-11 EP EP04768838A patent/EP1678169B1/en active Active
- 2004-10-11 WO PCT/GB2004/004307 patent/WO2005040159A1/en active Application Filing
- 2004-10-11 CA CA002542522A patent/CA2542522A1/en not_active Abandoned
- 2004-10-11 ES ES04768838T patent/ES2328820T3/es active Active
- 2004-10-11 BR BRPI0415398-7A patent/BRPI0415398A/pt not_active IP Right Cessation
- 2004-10-11 KR KR1020067009627A patent/KR20060123164A/ko not_active Application Discontinuation
- 2004-10-11 US US10/595,390 patent/US7579349B2/en not_active Expired - Fee Related
- 2004-10-11 JP JP2006534814A patent/JP2007510626A/ja active Pending
- 2004-10-11 AU AU2004283137A patent/AU2004283137A1/en not_active Abandoned
- 2004-10-11 DE DE602004022187T patent/DE602004022187D1/de active Active
- 2004-10-14 TW TW093131214A patent/TW200530229A/zh unknown
- 2004-10-15 AR ARP040103757A patent/AR046338A1/es unknown
- 2004-10-15 UY UY28565A patent/UY28565A1/es not_active Application Discontinuation
- 2004-10-16 SA SA04250338A patent/SA04250338B1/ar unknown
-
2006
- 2006-04-11 IL IL174989A patent/IL174989A0/en unknown
- 2006-05-12 NO NO20062130A patent/NO20062130L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200530229A (en) | 2005-09-16 |
BRPI0415398A (pt) | 2006-12-19 |
UY28565A1 (es) | 2005-05-31 |
US20070037888A1 (en) | 2007-02-15 |
EP1678169B1 (en) | 2009-07-22 |
IL174989A0 (en) | 2006-08-20 |
WO2005040159A1 (en) | 2005-05-06 |
AU2004283137A1 (en) | 2005-05-06 |
CA2542522A1 (en) | 2005-05-06 |
ES2328820T3 (es) | 2009-11-18 |
DE602004022187D1 (de) | 2009-09-03 |
SA04250338B1 (ar) | 2008-11-18 |
JP2007510626A (ja) | 2007-04-26 |
AR046338A1 (es) | 2005-12-07 |
KR20060123164A (ko) | 2006-12-01 |
US7579349B2 (en) | 2009-08-25 |
EP1678169A1 (en) | 2006-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062130L (no) | 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft | |
ATE318267T1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
NO20062763L (no) | Pyrrolotriazinforbindelser som kinaseinhibitorer | |
NO20081003L (no) | 2-Aminopyrimidinderivater som modulatorer av histamin-H4-reseptoraktivitet | |
ATE360627T1 (de) | Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren | |
NO20044995L (no) | Heterosykliske forbindelser | |
DK1318992T3 (da) | Imidazolderivater som Raf-kinaseinhibitorer | |
NO20054852L (no) | GFAT inhibitorer | |
MY141521A (en) | 5-substituted-six-membered heteroaromatic glucokinase activators | |
TR200201144T2 (tr) | NFKB aktivitesinin modülasyonu için ikame edilmiş indoller | |
AU2003226572A1 (en) | Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors | |
MXPA05009063A (es) | Compuestos de aminoheteroarilo como inhibidores de proteina cinasa. | |
ATE324371T1 (de) | N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten | |
ATE477256T1 (de) | Thienylverbindungen | |
NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
NO20044526L (no) | Hemisterlinderivater og anvendelser derav | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
NO20061316L (no) | Imidazopyndinderivater som induserbare NO-syntaseinhibitorer | |
ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
NO20074869L (no) | Pyrimidinderivater for anvendelse som antikreftmidler | |
UA80474C2 (en) | Aminoheteroaryl compounds as inhibitors of protein kinase | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
DE60215918D1 (de) | Azofarbstoffe | |
ATE276259T1 (de) | Dihydroporphyrinderivate und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |